BG107463A - Clear aqueous anaesthetic composition - Google Patents

Clear aqueous anaesthetic composition

Info

Publication number
BG107463A
BG107463A BG107463A BG10746303A BG107463A BG 107463 A BG107463 A BG 107463A BG 107463 A BG107463 A BG 107463A BG 10746303 A BG10746303 A BG 10746303A BG 107463 A BG107463 A BG 107463A
Authority
BG
Bulgaria
Prior art keywords
clear aqueous
propofol
compositions
composition
hydroxypropyl
Prior art date
Application number
BG107463A
Other languages
Bulgarian (bg)
English (en)
Inventor
Srikanth Pai
Sangeeta Rivankar
Shilpa Kocharekar
Original Assignee
Bharat Serums & Vaccines Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bharat Serums & Vaccines Ltd. filed Critical Bharat Serums & Vaccines Ltd.
Publication of BG107463A publication Critical patent/BG107463A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG107463A 2000-06-21 2003-01-16 Clear aqueous anaesthetic composition BG107463A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN573MU2000 IN187686B (fr) 2000-06-21 2000-06-21
PCT/IN2000/000124 WO2001097796A1 (fr) 2000-06-21 2000-12-14 Composition anesthesique aqueuse claire

Publications (1)

Publication Number Publication Date
BG107463A true BG107463A (en) 2003-11-28

Family

ID=11097257

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107463A BG107463A (en) 2000-06-21 2003-01-16 Clear aqueous anaesthetic composition

Country Status (26)

Country Link
US (1) US7138387B2 (fr)
EP (1) EP1299095B1 (fr)
JP (1) JP4907833B2 (fr)
KR (1) KR100810066B1 (fr)
CN (1) CN1254237C (fr)
AP (1) AP2002002674A0 (fr)
AT (1) ATE267592T1 (fr)
AU (2) AU2001235972B2 (fr)
BG (1) BG107463A (fr)
BR (1) BR0017268A (fr)
CA (1) CA2414064C (fr)
DE (1) DE60011149T2 (fr)
DK (1) DK1299095T3 (fr)
EA (1) EA005589B1 (fr)
ES (1) ES2222271T3 (fr)
HU (1) HUP0301646A3 (fr)
IL (1) IL153387A0 (fr)
IN (1) IN187686B (fr)
MX (1) MXPA02012611A (fr)
NO (1) NO20025999L (fr)
NZ (1) NZ523643A (fr)
PL (1) PL359624A1 (fr)
PT (1) PT1299095E (fr)
WO (1) WO2001097796A1 (fr)
YU (1) YU2703A (fr)
ZA (1) ZA200300336B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN188917B (fr) * 2000-12-07 2002-11-23 Bharat Surums & Vaccines Ltd
US7034013B2 (en) 2001-03-20 2006-04-25 Cydex, Inc. Formulations containing propofol and a sulfoalkyl ether cyclodextrin
US20050042280A1 (en) * 2001-12-28 2005-02-24 Rogers Tracey L. Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
EP1469886B8 (fr) * 2002-02-01 2008-01-09 Shimoda Biotech (PTY) LTD Composition pharmaceutique lyophilisée de propofole
US7550155B2 (en) 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
CA2494297C (fr) 2002-07-29 2011-10-18 Transform Pharmaceuticals, Inc. Compositions pharmaceutiques de 2,6-diisopropylphenol aqueux
KR20200083657A (ko) * 2002-12-09 2020-07-08 아브락시스 바이오사이언스, 엘엘씨 약리학적 물질의 조성물 및 그 전달방법
JPWO2005067905A1 (ja) * 2004-01-14 2007-12-27 株式会社大塚製薬工場 プロポフォール含有脂肪乳剤
EA200700440A1 (ru) * 2004-09-13 2008-02-28 Бхарат Сирумс Энд Вэксинс Лтд. Композиции стабильных эмульсий для внутривенного введения, имеющие защитную эффективность
BRPI0614628A2 (pt) * 2005-08-12 2011-04-12 Bharat Serums & Vaccines Ltd composição anestésica aquosa adequada para a administração parenteral; processo de produção de uma composição anestésica aquosa adequada para a administração parenteral; composição anestésica aquosa; e processo de produção de uma composição anestésica aquosa
WO2007128866A2 (fr) * 2006-05-09 2007-11-15 Novobion Oy Nouvelles compositions chimiques
TWI450043B (zh) * 2008-03-11 2014-08-21 3M Innovative Properties Co 具備保護層之光工具
WO2010148288A2 (fr) * 2009-06-19 2010-12-23 Lyotropic Therapeutics, Inc. Formulations pharmaceutiques avec de faibles taux aqueux de médicament non lié libre
US9096712B2 (en) 2009-07-21 2015-08-04 3M Innovative Properties Company Curable compositions, method of coating a phototool, and coated phototool
KR101781659B1 (ko) 2009-09-16 2017-09-25 쓰리엠 이노베이티브 프로퍼티즈 컴파니 플루오르화된 코팅 및 그로 제조된 포토툴
KR101768237B1 (ko) 2009-09-16 2017-08-14 쓰리엠 이노베이티브 프로퍼티즈 컴파니 플루오르화된 코팅 및 그로 제조된 포토툴
US8268067B2 (en) * 2009-10-06 2012-09-18 3M Innovative Properties Company Perfluoropolyether coating composition for hard surfaces
EP2345427A1 (fr) * 2010-01-14 2011-07-20 SapioTec GmbH Complexe de flurane
DK2484350T3 (en) * 2011-02-04 2016-08-01 Norbert Univ -Prof Dr Med Roewer A pharmaceutical composition containing a complex of a cyclodextrin with a propofolsalt
AU2013273764B2 (en) * 2011-11-29 2016-05-05 Zoetis Services Llc Pharmaceutical compositions
KR101922752B1 (ko) * 2011-11-29 2018-11-27 주록스 피티와이 리미티드 사이클로덱스트린 및 소수성 약물을 포함하는 주사용 약제학적 조성물을 보존하는 방법
CN103263404B (zh) * 2012-04-28 2017-12-01 中国人民解放军军事医学科学院放射与辐射医学研究所 一种复合麻醉药物
IL304912A (en) 2012-08-21 2023-10-01 Sage Therapeutics Inc Treatment methods for epilepsy and status epilepticus
US10646439B2 (en) * 2016-01-29 2020-05-12 Cuda Anesthetics, Llc Aqueous pharmaceutical formulation comprising propofol
FR3117337B1 (fr) 2020-12-10 2023-04-28 Centre Hospitalier Univ De Lille Composition pharmaceutique contenant du propofol, une cyclodextrine ou un dérivé de cyclodextrine et un sel pharmaceuticalement acceptable

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA962214B (en) * 1995-04-10 1996-10-07 Farmarc Nederland Bv Pharmaceutical composition

Also Published As

Publication number Publication date
NZ523643A (en) 2004-05-28
NO20025999D0 (no) 2002-12-13
ATE267592T1 (de) 2004-06-15
HUP0301646A2 (hu) 2003-09-29
YU2703A (sh) 2006-03-03
AU3597201A (en) 2002-01-02
AU2001235972B2 (en) 2005-07-21
CA2414064A1 (fr) 2001-12-27
AP2002002674A0 (en) 2002-12-31
JP2003535893A (ja) 2003-12-02
HUP0301646A3 (en) 2005-06-28
BR0017268A (pt) 2003-05-27
PL359624A1 (en) 2004-08-23
ZA200300336B (en) 2004-04-08
WO2001097796A1 (fr) 2001-12-27
CA2414064C (fr) 2013-01-08
KR20030023875A (ko) 2003-03-20
IL153387A0 (en) 2003-07-06
MXPA02012611A (es) 2004-07-30
US7138387B2 (en) 2006-11-21
KR100810066B1 (ko) 2008-03-05
JP4907833B2 (ja) 2012-04-04
PT1299095E (pt) 2004-10-29
CN1454085A (zh) 2003-11-05
EA005589B1 (ru) 2005-04-28
CN1254237C (zh) 2006-05-03
DE60011149D1 (de) 2004-07-01
EA200300047A1 (ru) 2003-06-26
NO20025999L (no) 2002-12-13
DK1299095T3 (da) 2004-10-11
EP1299095B1 (fr) 2004-05-26
IN187686B (fr) 2002-06-08
EP1299095A1 (fr) 2003-04-09
DE60011149T2 (de) 2005-07-07
US20040014718A1 (en) 2004-01-22
ES2222271T3 (es) 2005-02-01

Similar Documents

Publication Publication Date Title
BG107463A (en) Clear aqueous anaesthetic composition
CA2910494C (fr) Conjugues insuline-oligomere, preparations et utilisations de ceux-ci
UY26635A1 (es) Métodos sinérgicos y composiciones para el tratamiento del cáncer
DK1157037T3 (da) GCSF-konjugater
ATE409048T1 (de) Pharmazeutisch aktive oligosaccharid-conjugate
TWI256891B (en) 17alpha-alkyl-17beta-oxy-estratrienes and intermediate products for their production, use of the 17alpha-alkyl-17beta-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations
SE0001899D0 (sv) New compounds
GEP20022788B (en) Pharmaceutical Compositions Having Appetite Suppressant Activity
CA2289202A1 (fr) Formulations pharmaceutiques solides contenant un melange physique de sulfoalkyl ether cyclodextrine et un agent therapeutique
RS20050066A (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
HK1102991A1 (en) Pharmaceutical formulation of decitabine
SG146648A1 (en) Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
AR032204A1 (es) Complejos de inclusion de ciclodextrina-drospirenona
NZ597354A (en) Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
HUT75513A (en) Taxane class derivative based pharmaceutical compositions and their preparation
BR0109672A (pt) Uso de zd6126 ou de um seu sal farmaceuticamente aceitável e um de: um agente antitumoral de plantina e um taxano, composição farmacêutica, produto de combinação, kit, e, método para a produção de um efeito de danificação vascular em um animal de sangue quente
ES2105923B1 (es) Composiciones para el tratamiento de una infeccion y una enfermedad causadas por el virus de la hepatitis b (hbv).
AR028987A1 (es) Compuesto derivado de ciclopentapiridin-cetona, composicion farmaceutica que lo contiene y su uso en la fabricacion de un medicamento util para tratar una enfermedad
BR0109617A (pt) Composição farmacêutica, oligossacarìdeo, processo de preparação de oligossacarìdeos, e, utilização de oligossacarìdeos
AU6749401A (en) Use of aloe-emodin in the treatment of neuroectodermal tumors
HUP0303379A2 (hu) Savérzékeny vegyületek, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
AR038017A1 (es) Composicion anestesica acuosa y clara
IL147901A0 (en) Phenanthroline-7-one derivatives and their therapeutic uses
BR0316968A (pt) Composições estáveis, claras, aquosas de ifosfamida para administração parenteral que apresentam pouca toxicidade; processo para a preparação de composições de ifosfamida; e composições de ifosfamida e um processo para a preparação das mesmas
YU87302A (sh) Inhibitori 11-beta-hidroksi steroidne dehidrogenaze, tip 1